deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT05018299

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma

A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma

Sponsor: Oneness Biotech Co., Ltd.

Conditions Severe Asthma
Interventions FB704A FB704A placebo
Updated 10 times since 2021 Last updated: Dec 2, 2025 Started: Sep 30, 2021 Primary completion: Feb 13, 2026 Completion: May 8, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Severe Asthma, this trial is actively recruiting participants. The trial is conducted by Oneness Biotech Co., Ltd. and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshotRecruiting~Oct 2021 – ~May 2022 · 7 months · monthly snapshotRecruiting~May 2022 – ~Aug 2023 · 15 months · monthly snapshotRecruiting~Aug 2023 – ~Feb 2024 · 6 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshotRecruiting~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshotUnknown~Jan 2026 – present · 8 months · monthly snapshotRecruiting

Change History

10 versions recorded

  1. Jan 2026 — Present [monthly]

    Recruiting PHASE2

    Status: Unknown → Recruiting

  2. Nov 2025 — Jan 2026 [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  3. Sep 2025 — Nov 2025 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

▶ Show 5 earlier versions

  1. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  2. Aug 2023 — Feb 2024 [monthly]

    Recruiting PHASE2

  3. May 2022 — Aug 2023 [monthly]

    Recruiting PHASE2

  4. Oct 2021 — May 2022 [monthly]

    Recruiting PHASE2

  5. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oneness Biotech Co., Ltd.
Data source: Oneness Biotech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations